R
Richard L. Wahl
Researcher at Washington University in St. Louis
Publications - 379
Citations - 29474
Richard L. Wahl is an academic researcher from Washington University in St. Louis. The author has contributed to research in topics: Positron emission tomography & Standardized uptake value. The author has an hindex of 77, co-authored 346 publications receiving 26911 citations. Previous affiliations of Richard L. Wahl include Memorial Sloan Kettering Cancer Center & Johns Hopkins University School of Medicine.
Papers
More filters
Journal ArticleDOI
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
TL;DR: Qualitative and quantitative approaches to 18F-FDG PET response assessment have been applied and require a consistent PET methodology to allow quantitative assessments and the proposed PERCIST 1.0 criteria should serve as a starting point for use in clinical trials and in structured quantitative clinical reporting.
Journal ArticleDOI
American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer
Gary H. Lyman,Armando E. Giuliano,Mark R. Somerfield,Al B. Benson,Diane C. Bodurka,Harold J. Burstein,Alistair J. Cochran,Hiram S. Cody,Stephen B. Edge,Sharon Galper,James A. Hayman,Theodore Y. Kim,Cheryl L. Perkins,Donald A. Podoloff,Visa Haran Sivasubramaniam,Roderick R. Turner,Richard L. Wahl,Donald L. Weaver,Antonio C. Wolff,Eric P. Winer +19 more
TL;DR: A review of the available evidence demonstrates that, when performed by experienced clinicians, SNB appears to be a safe and acceptably accurate method for identifying early-stage breast cancer without involvement of the axillary lymph nodes.
Journal ArticleDOI
Recommendations on the Use of 18F-FDG PET in Oncology
James W. Fletcher,James W. Fletcher,Benjamin Djulbegovic,Heloisa P. Soares,Barry A. Siegel,Val J. Lowe,Gary H. Lyman,R. Edward Coleman,Richard L. Wahl,John Christopher Paschold,Norbert Avril,Lawrence H. Einhorn,W. Warren Suh,David Samson,Dominique Delbeke,Mark Gorman,Anthony F. Shields +16 more
TL;DR: In this article, the authors developed recommendations on the use of 18F-FDG PET in breast, colorectal, esophageal, head and neck, lung, pancreatic and thyroid cancer; lymphoma, melanoma, and sarcoma; and unknown primary tumor.
Journal ArticleDOI
Pitfalls in Oncologic Diagnosis with FDG PET Imaging: Physiologic and Benign Variants
TL;DR: Proper interpretation ofFDG PET images requires knowledge of the normal physiologic distribution of the tracer, frequently encountered physiologic variants, and benign pathologic causes of FDG uptake that can be confused with a malignant neoplasm.
Journal ArticleDOI
131I-tositumomab therapy as initial treatment for follicular lymphoma.
Mark S. Kaminski,Melissa Tuck,Judith Estes,Arne Kolstad,Charles W. Ross,Kenneth R. Zasadny,Denise Regan,Paul V. Kison,Susan J. Fisher,Stewart M. Kroll,Richard L. Wahl +10 more
TL;DR: A single one-week course of 131I-tositumomab therapy as initial treatment can induce prolonged clinical and molecular remissions in patients with advanced follicular lymphoma.